It's Not All About the Journal Impact Factor.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37778766.
- Also identified by DOI 10.3899/jrheum.2022-1338.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We read with great interest the recent Panorama article that discussed the rise in the Journal Impact Factor (JIF) of rheumatology journals and the potential effect of the coronavirus disease 19 (COVID-19) pandemic in this rise.<sup>1</sup> Although there has definitely been a rise in the JIF of journals following the COVID-19 pandemic, there are concerns about some aspects of the paper that we wish to discuss in this letter.<sup>2</sup>.